Ho WS and Gardiner SM |
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. |
2009 |
Br. J. Pharmacol. |
pmid:19133994
|
Kirkham TC et al. |
Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. |
2002 |
Br. J. Pharmacol. |
pmid:12055133
|
Price TJ et al. |
Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide. |
2004 |
Br. J. Pharmacol. |
pmid:15006899
|
Taddei S |
Evolving the concept of regulation of vascular tone in humans. |
2005 |
Br. J. Pharmacol. |
pmid:15997231
|
Klegeris A et al. |
Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor. |
2003 |
Br. J. Pharmacol. |
pmid:12813001
|
Moreno-Sanz G et al. |
Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier. |
2012 |
Br. J. Pharmacol. |
pmid:22774772
|
Chang L et al. |
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. |
2006 |
Br. J. Pharmacol. |
pmid:16501580
|
Thors L et al. |
Inhibition of the cellular uptake of anandamide by genistein and its analogue daidzein in cells with different levels of fatty acid amide hydrolase-driven uptake. |
2007 |
Br. J. Pharmacol. |
pmid:17676056
|
Smart D et al. |
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). |
2000 |
Br. J. Pharmacol. |
pmid:10694225
|
Pakdeechote P et al. |
Cannabinoids inhibit noradrenergic and purinergic sympathetic cotransmission in the rat isolated mesenteric arterial bed. |
2007 |
Br. J. Pharmacol. |
pmid:17641668
|
Fleming I et al. |
Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists. |
1999 |
Br. J. Pharmacol. |
pmid:10193775
|
Evans RM et al. |
Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. |
2007 |
Br. J. Pharmacol. |
pmid:17700720
|
Wheal AJ et al. |
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats. |
2007 |
Br. J. Pharmacol. |
pmid:17700721
|
Matias I et al. |
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. |
2007 |
Br. J. Pharmacol. |
pmid:17704823
|
Mendiguren A and Pineda J |
Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices. |
2009 |
Br. J. Pharmacol. |
pmid:19845674
|
Herradón E et al. |
Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta. |
2007 |
Br. J. Pharmacol. |
pmid:17704831
|
Whyte LS et al. |
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro. |
2012 |
Br. J. Pharmacol. |
pmid:21649637
|
Evans RM et al. |
Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites. |
2008 |
Br. J. Pharmacol. |
pmid:18376419
|
Kawahara H et al. |
Inhibition of fatty acid amide hydrolase unmasks CB1 receptor and TRPV1 channel-mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey. |
2011 |
Br. J. Pharmacol. |
pmid:21175570
|
De Petrocellis L et al. |
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. |
2011 |
Br. J. Pharmacol. |
pmid:21175579
|
Stanford SJ et al. |
Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat. |
2001 |
Br. J. Pharmacol. |
pmid:11454655
|
Mang CF et al. |
Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors. |
2001 |
Br. J. Pharmacol. |
pmid:11522608
|
White R and Hiley CR |
A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. |
1997 |
Br. J. Pharmacol. |
pmid:9422801
|
Mechoulam R |
Plant cannabinoids: a neglected pharmacological treasure trove. |
2005 |
Br. J. Pharmacol. |
pmid:16205721
|
Zygmunt PM et al. |
Studies on the effects of anandamide in rat hepatic artery. |
1997 |
Br. J. Pharmacol. |
pmid:9422814
|
Thomas A et al. |
Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. |
2005 |
Br. J. Pharmacol. |
pmid:16205722
|
Aquila S et al. |
Rimonabant (SR141716) induces metabolism and acquisition of fertilizing ability in human sperm. |
2010 |
Br. J. Pharmacol. |
pmid:20067470
|
Bisogno T et al. |
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. |
2001 |
Br. J. Pharmacol. |
pmid:11606325
|
Li H et al. |
Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells. |
2013 |
Br. J. Pharmacol. |
pmid:23347118
|
Evans RM et al. |
Multiple actions of anandamide on neonatal rat cultured sensory neurones. |
2004 |
Br. J. Pharmacol. |
pmid:15023857
|
Stein EA et al. |
Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. |
1996 |
Br. J. Pharmacol. |
pmid:8872363
|
Thors L et al. |
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids. |
2008 |
Br. J. Pharmacol. |
pmid:18552875
|
O'Brien LD et al. |
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus). |
2013 |
Br. J. Pharmacol. |
pmid:23991698
|
Plane F et al. |
Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. |
1997 |
Br. J. Pharmacol. |
pmid:9283682
|
Gaskari SA et al. |
Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. |
2005 |
Br. J. Pharmacol. |
pmid:16025138
|
De Petrocellis L et al. |
Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. |
2004 |
Br. J. Pharmacol. |
pmid:15289293
|
Bittner S et al. |
TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system. |
2009 |
Brain |
pmid:19570851
|
Centonze D et al. |
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. |
2007 |
Brain |
pmid:17626034
|
Butti E et al. |
Subventricular zone neural progenitors protect striatal neurons from glutamatergic excitotoxicity. |
2012 |
Brain |
pmid:23008234
|
Patel RR et al. |
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol. |
2016 |
Brain |
pmid:27267376
|
Doenni VM et al. |
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. |
2016 |
Brain Behav. Immun. |
pmid:27453335
|
Rossi S et al. |
Cannabinoid CB1 receptors regulate neuronal TNF-α effects in experimental autoimmune encephalomyelitis. |
2011 |
Brain Behav. Immun. |
pmid:21473912
|
Mecha M et al. |
Endocannabinoids drive the acquisition of an alternative phenotype in microglia. |
2015 |
Brain Behav. Immun. |
pmid:26086345
|
Correa F et al. |
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells. |
2011 |
Brain Behav. Immun. |
pmid:21310228
|
Christopoulos A and Wilson K |
Interaction of anandamide with the M(1) and M(4) muscarinic acetylcholine receptors. |
2001 |
Brain Res. |
pmid:11578621
|
Patel NA et al. |
Arachidonylethanolamide (AEA) activation of FOS proto-oncogene protein immunoreactivity in the rat brain. |
1998 |
Brain Res. |
pmid:9666136
|
Nicholson RA et al. |
Sodium channel inhibition by anandamide and synthetic cannabimimetics in brain. |
2003 |
Brain Res. |
pmid:12834914
|
Soni N et al. |
Anandamide and 2-AG are endogenously present within the laterodorsal tegmental nucleus: Functional implications for a role of eCBs in arousal. |
2017 |
Brain Res. |
pmid:28404451
|
Stefano GB et al. |
Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release. |
1997 |
Brain Res. |
pmid:9125406
|
Romero J et al. |
Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. |
1995 |
Brain Res. |
pmid:8974649
|